$CURR strong quarter for the company: Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins https://finance.yahoo.com/news/cure-pharmaceutical-reports-second-quarter-100000381.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance